CME Group Inc (CME) - Net Assets
Based on the latest financial reports, CME Group Inc (CME) has net assets worth $28.73 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($198.55 Billion) and total liabilities ($169.82 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CME Group Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.73 Billion |
| % of Total Assets | 14.47% |
| Annual Growth Rate | 22.96% |
| 5-Year Change | 4.85% |
| 10-Year Change | 41.24% |
| Growth Volatility | 137.83 |
CME Group Inc - Net Assets Trend (2000–2025)
This chart illustrates how CME Group Inc's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of CME Group Inc for the complete picture of this company's asset base.
Annual Net Assets for CME Group Inc (2000–2025)
The table below shows the annual net assets of CME Group Inc from 2000 to 2025. For live valuation and market cap data, see market value of CME Group Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $28.73 Billion | +8.46% |
| 2024-12-31 | $26.49 Billion | -0.94% |
| 2023-12-31 | $26.74 Billion | -0.52% |
| 2022-12-31 | $26.88 Billion | -1.90% |
| 2021-12-31 | $27.40 Billion | +3.98% |
| 2020-12-31 | $26.35 Billion | +0.73% |
| 2019-12-31 | $26.16 Billion | +0.75% |
| 2018-12-31 | $25.97 Billion | +15.86% |
| 2017-12-31 | $22.41 Billion | +10.18% |
| 2016-12-31 | $20.34 Billion | -1.03% |
| 2015-12-31 | $20.55 Billion | -1.78% |
| 2014-12-31 | $20.92 Billion | -1.12% |
| 2013-12-31 | $21.16 Billion | -1.61% |
| 2012-12-31 | $21.51 Billion | -0.54% |
| 2011-12-31 | $21.62 Billion | +7.42% |
| 2010-12-31 | $20.13 Billion | +4.29% |
| 2009-12-31 | $19.30 Billion | +3.28% |
| 2008-12-31 | $18.69 Billion | +51.87% |
| 2007-12-31 | $12.31 Billion | +710.07% |
| 2006-12-31 | $1.52 Billion | +35.79% |
| 2005-12-31 | $1.12 Billion | +37.67% |
| 2004-12-31 | $812.60 Million | +44.33% |
| 2003-12-31 | $563.00 Million | +26.19% |
| 2002-12-31 | $446.14 Million | +79.63% |
| 2001-12-31 | $248.37 Million | +51.75% |
| 2000-12-31 | $163.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CME Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5282.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.43 Billion | 22.39% |
| Common Stock | $3.60 Million | 0.01% |
| Other Comprehensive Income | $81.90 Million | 0.29% |
| Other Components | $22.21 Billion | 77.31% |
| Total Equity | $28.73 Billion | 100.00% |
CME Group Inc Competitors by Market Cap
The table below lists competitors of CME Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sanofi
F:SNW2
|
$105.72 Billion |
|
Bank of Montreal
TO:BMO
|
$105.76 Billion |
|
Lockheed Martin Corporation
NYSE:LMT
|
$106.03 Billion |
|
State Bank of India
NSE:SBIN
|
$106.66 Billion |
|
Cambricon Technologies Corp Ltd
SHG:688256
|
$104.90 Billion |
|
Medtronic plc
SA:MDTC34
|
$104.84 Billion |
|
Mizuho Financial Group Inc.
NYSE:MFG
|
$104.09 Billion |
|
AIR LIQUIDE ADR 1/5/EO 11
F:AILA
|
$103.86 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CME Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 26,486,900,000 to 28,728,200,000, a change of 2,241,300,000 (8.5%).
- Net income of 4,044,400,000 contributed positively to equity growth.
- Dividend payments of 3,933,000,000 reduced retained earnings.
- Share repurchases of 266,100,000 reduced equity.
- Other comprehensive income increased equity by 187,400,000.
- Other factors increased equity by 2,208,600,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $4.04 Billion | +14.08% |
| Dividends Paid | $3.93 Billion | -13.69% |
| Share Repurchases | $266.10 Million | -0.93% |
| Other Comprehensive Income | $187.40 Million | +0.65% |
| Other Changes | $2.21 Billion | +7.69% |
| Total Change | $- | 8.46% |
Book Value vs Market Value Analysis
This analysis compares CME Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 254.52x to 3.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-12-31 | $1.14 | $289.54 | x |
| 2001-12-31 | $1.70 | $289.54 | x |
| 2002-12-31 | $2.97 | $289.54 | x |
| 2003-12-31 | $3.32 | $289.54 | x |
| 2004-12-31 | $4.72 | $289.54 | x |
| 2005-12-31 | $6.42 | $289.54 | x |
| 2006-12-31 | $8.65 | $289.54 | x |
| 2007-12-31 | $55.80 | $289.54 | x |
| 2008-12-31 | $63.39 | $289.54 | x |
| 2009-12-31 | $58.01 | $289.54 | x |
| 2010-12-31 | $60.54 | $289.54 | x |
| 2011-12-31 | $64.77 | $289.54 | x |
| 2012-12-31 | $64.71 | $289.54 | x |
| 2013-12-31 | $63.28 | $289.54 | x |
| 2014-12-31 | $62.26 | $289.54 | x |
| 2015-12-31 | $60.82 | $289.54 | x |
| 2016-12-31 | $60.01 | $289.54 | x |
| 2017-12-31 | $65.87 | $289.54 | x |
| 2018-12-31 | $75.54 | $289.54 | x |
| 2019-12-31 | $73.02 | $289.54 | x |
| 2020-12-31 | $73.50 | $289.54 | x |
| 2021-12-31 | $76.34 | $289.54 | x |
| 2022-12-31 | $74.83 | $289.54 | x |
| 2023-12-31 | $74.38 | $289.54 | x |
| 2024-12-31 | $73.59 | $289.54 | x |
| 2025-12-31 | $79.75 | $289.54 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CME Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.08%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 62.02%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 6.91x
- Recent ROE (14.08%) is above the historical average (11.66%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -3.61% | -2.61% | 0.59x | 2.33x | $-22.28 Million |
| 2001 | 27.50% | 17.22% | 0.19x | 8.32x | $43.47 Million |
| 2002 | 21.08% | 20.05% | 0.14x | 7.52x | $49.45 Million |
| 2003 | 21.69% | 22.78% | 0.11x | 8.65x | $65.83 Million |
| 2004 | 27.02% | 29.17% | 0.26x | 3.52x | $138.30 Million |
| 2005 | 27.43% | 31.40% | 0.25x | 3.55x | $194.99 Million |
| 2006 | 26.82% | 37.37% | 0.25x | 2.83x | $255.44 Million |
| 2007 | 5.35% | 37.50% | 0.09x | 1.65x | $-572.03 Million |
| 2008 | 3.83% | 27.94% | 0.05x | 2.58x | $-1.15 Billion |
| 2009 | 4.28% | 31.61% | 0.07x | 1.85x | $-1.10 Billion |
| 2010 | 4.73% | 31.67% | 0.09x | 1.74x | $-1.06 Billion |
| 2011 | 8.38% | 55.24% | 0.08x | 1.89x | $-349.93 Million |
| 2012 | 4.17% | 30.75% | 0.07x | 1.81x | $-1.25 Billion |
| 2013 | 4.62% | 33.27% | 0.05x | 2.57x | $-1.14 Billion |
| 2014 | 5.39% | 36.21% | 0.04x | 3.45x | $-965.25 Million |
| 2015 | 6.07% | 37.48% | 0.05x | 3.28x | $-808.18 Million |
| 2016 | 7.54% | 42.67% | 0.05x | 3.41x | $-499.97 Million |
| 2017 | 18.13% | 111.49% | 0.05x | 3.38x | $1.82 Billion |
| 2018 | 7.56% | 45.53% | 0.06x | 2.98x | $-634.33 Million |
| 2019 | 8.09% | 43.48% | 0.06x | 2.88x | $-499.43 Million |
| 2020 | 7.99% | 43.11% | 0.04x | 4.73x | $-529.95 Million |
| 2021 | 9.62% | 56.22% | 0.02x | 7.18x | $-103.53 Million |
| 2022 | 10.01% | 53.61% | 0.03x | 6.48x | $3.13 Million |
| 2023 | 12.07% | 57.83% | 0.04x | 4.85x | $552.41 Million |
| 2024 | 13.31% | 57.52% | 0.04x | 5.19x | $877.11 Million |
| 2025 | 14.08% | 62.02% | 0.03x | 6.91x | $1.17 Billion |
Industry Comparison
This section compares CME Group Inc's net assets metrics with peer companies in the Financial Data & Stock Exchanges industry.
Industry Context
- Industry: Financial Data & Stock Exchanges
- Average net assets among peers: $3,784,027,786
- Average return on equity (ROE) among peers: -16.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CME Group Inc (CME) | $28.73 Billion | -3.61% | 5.91x | $105.05 Billion |
| Bit Origin Ltd (BTOG) | $10.26 Million | -274.98% | 0.30x | $3.28 Million |
| Coinbase Global Inc (COIN) | $14.79 Billion | 8.52% | 1.01x | $42.66 Billion |
| Dun & Bradstreet Holdings Inc. (DNB) | $-17.70 Million | 0.00% | 0.00x | $4.08 Billion |
| FactSet Research Systems Inc (FDS) | $500.83 Million | 28.94% | 0.26x | $7.85 Billion |
| Intercontinental Exchange Inc (ICE) | $12.94 Billion | 1.96% | 4.01x | $87.66 Billion |
| Moodys Corporation (MCO) | $3.73 Billion | 55.22% | 3.16x | $81.13 Billion |
| Marketwise Inc (MKTW) | $-405.26 Million | 0.00% | 0.00x | $42.82 Million |
| Morningstar Inc (MORN) | $934.70 Million | 19.58% | 0.56x | $6.75 Billion |
| MSCI Inc (MSCI) | $1.58 Billion | 14.12% | 0.99x | $40.30 Billion |
About CME Group Inc
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house ser… Read more